Jul 7, 2021 | All Posts, Controlled Release, Drug Bioavailability, Main Blog, Peptide |
A prodrug is a medication or compound that metabolizes into a pharmacologically active drug after administration, offering opportunities to optimize the pharmaceutical property to improve bioavailability. Approximately 10% of all marketed drugs worldwide can be...
Mar 13, 2021 | All Posts, Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Given the rise of peptide and protein therapeutics in the pharmaceutical landscape, identifying the right delivery strategies that are patient-friendly and can be used over broad dose ranges has always been important considerations for the discovery and development of...
Apr 14, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Physiologically based pharmacokinetic modeling is well established in the pharmaceutical industry and is accepted by regulatory agencies for the prediction of drug–drug interactions. However, physiologically based pharmacokinetic modeling is valuable to address a much...
Apr 13, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Oral Peptide Therapeutics – Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realize the vast potential. Numerous technologies are currently in...
Apr 12, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
There are various light-scattering tools available to the pharma/biotech industry. One such company ‘Wyatt Technology’, provides macromolecular and nanoparticle characterization solutions recognised by the FDA and several related technologies to their...
Recent Comments